Novo Nordisk A/S confirms Wegovy pill recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class

[출처/시간] Briefing.com - 9:25 AM ET, 05/22/2026 With a mean weight loss of 16.6%1, Wegovy pill demonstrates best-in-class weight-loss efficacy and is the first oral GLP-1 treatment recommended by CHMP for weight management in the EU.CHMP recommends Wegovy pill for approval to reduce excess body weight and maintain long-term weight reduction. The recommendation also includes data from SELECT which demonstrates that Weg

뉴스 | admin | May 22, 2026